2025
This week on Science Quickly, we break down the 2025 Nobel Prizes in Physiology or Medicine, Physics and Chemistry. We also unpack the Centers for Disease Contr…
Many of us are taught from a young age that being “good” means being obedient—but that conditioning can make it hard to speak up when it counts. In this episode…
Headaches are among the most common human experiences—yet science still struggles to explain them. Journalist Tom Zeller, Jr., joins host Rachel Feltman to expl…
Zoya Teirstein, a senior staff writer at Grist, joins host Kendra Pierre-Louis to talk about this year’s United Nations Climate Change Conference, or COP30, whi…
In this episode of Science Quickly, we dive into how the European Union’s latest Copernicus Climate Change Service bulletin shows that 2025 is on track to becom…
In this year-end roundup, Scientific American editors break down how 2025 reshaped science across the board—from sweeping federal upheavals that disrupted long-…
Drugs known as glucagon-like peptide-1 receptor agonists, colloquially called GLP-1 medications, have gone from relatively obscure diabetes treatments to blockb…
I called it a year in review but it's so much more.
Welcome to a special edition of What’s new in ViteLand! Regularly, we recap the project updates for Vite, Vitest, Oxc, Rolldown and what’s happening in our comm…
I gave an opening keynote at the FIDO Alliance’s “Authenticate” conference a few weeks ago! Although it featured timely strategies and tips for professionals de…





